Fabio
3.0 KiB
3.0 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Relates to prescription drug formulary changes during a contract year; repealer | Prohibits health care plans that provide essential benefits under the Affordable Care Act from removing a prescription drug from a formulary or adding new or additional formulary restrictions from a formulary during a plan year; requires notice to policy holders of intent to remove a drug from a formulary; relates to the effectiveness of certain provisions of law relating thereto. | us/states/ny | New York Legislature | 2021-2022 | S 7767 | New York S 7767 (2021-2022) |
|
enacted |
|
1 | 11 | 3 | 2022-01-11 | 2022-02-24 | openstates | ocd-bill/d7f24d99-52a9-409e-8b5b-1479f2a14355 | http://www.nysenate.gov/legislation/bills/2021/S7767 | 9e181e5e14992f392138bd283a3468a21ccdda9b167e76120f0d6fe3eb104b8a | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
New York S 7767 (2021-2022) — Relates to prescription drug formulary changes during a contract year; repealer
Prohibits health care plans that provide essential benefits under the Affordable Care Act from removing a prescription drug from a formulary or adding new or additional formulary restrictions from a formulary during a plan year; requires notice to policy holders of intent to remove a drug from a formulary; relates to the effectiveness of certain provisions of law relating thereto.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- S7767 (committee substitute) — source
Votes
- Floor Vote — 53–9 (pass) · upper
- Assembly Vote — 143–0 (pass) · lower
- Rules Vote — 19–2 (pass) · upper
Sponsors
- BRESLIN — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2022-01-11 REFERRED TO RULES
referral-committee - 2022-01-18 ORDERED TO THIRD READING CAL.140
- 2022-01-24 PASSED SENATE
passage - 2022-01-24 DELIVERED TO ASSEMBLY
- 2022-01-24 REFERRED TO INSURANCE
referral-committee - 2022-01-25 SUBSTITUTED FOR A8697
- 2022-01-25 ORDERED TO THIRD READING CAL.301
- 2022-01-25 PASSED ASSEMBLY
passage - 2022-01-25 RETURNED TO SENATE
- 2022-02-24 DELIVERED TO GOVERNOR
executive-receipt - 2022-02-24 SIGNED CHAP.99
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/d7f24d99-52a9-409e-8b5b-1479f2a14355. Confidence: reported (aggregated from official New York legislature records).